Event Brief
UPDATED Jul 21, 2026 at 4:04 PM ET
Jul 21, 2026 at 9:04 AM ET
Novo Nordisk and Eli Lilly dispute weight-loss drug efficacy
By The BriefBrief
Novo Nordisk says Eli Lilly compared peak Zepbound doses to outdated, lower Wegovy doses.
WHO: Novo Nordisk
WHAT: Novo Nordisk claims Eli Lilly compared peak Zepbound doses against outdated, lower Wegovy doses in advertising.
WHEN: Jul 21, 2026 at 3:40 PM ET
WHERE: Location not specified
WHY: Novo Nordisk is disputing Eli Lilly's comparison of Zepbound and Wegovy dosing used for advertising.
Reporting from 3 identified publishers across this event arc.
View all 3 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Ortega says Nicaragua won’t hold elections soon
Daniel Ortega
Jul 21, 2026 at 4:05 PM ET
Hospital apologises after identity mix-up declared woman dead
Melbourne
Jul 21, 2026 at 4:05 PM ET
DOD says US forces sustained about 100 injuries in Iran war
United States
Jul 21, 2026 at 4:05 PM ET
U.S. condemns Ortega after he cancels Nicaragua elections
United States
Jul 21, 2026 at 4:04 PM ET
Page 12267 of 21449
Same format. Every time.
Continue reading — sign in or create a free account with
